Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 30 Schemes (22.06%)
Foreign Institutions
Held by 42 Foreign Institutions (5.35%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2022)
Net Profit:
-7 Million
Pharmaceuticals & Biotechnology
USD 0 Million ()
0
NA
0.00%
-1.17
-999,999.00%
0.00






